|  |  |  | Exenatide†| Placebo or Comparator | ||
---|---|---|---|---|---|---|---|
Study/Registry Number | Diabetes Management | Duration* (Weeks) | ITT (N) | Exposure (SY) | ITT (N) | Exposure (SY) | |
DeFronzo et al, 2005 18 | NCT00039013 | Met | 30 | 223 | 113.8 | 113 | 57.8 |
Buse et al, 2004 20 | NCT00039026 | SFU | 30 | 254 | 123.2 | 123 | 55.1 |
Kendall et al, 2005 19 | NCT00035984 | Met + SFU | 30 | 486 | 254.9 | 247 | 122.2 |
Zinman et al, 2007 24 | NCT00099320 | TZD ± Met | 16 | 121 | 31.7 | 112 | 32.3 |
Kadowaki et al, 2008 27 | NCT00382239 | SFU ± Met | 12 | 111 | 23.9 | 40 | 9.2 |
Gao, et al, 2009 26 | NCT00324363 | Met ± SFU | 16 | 234 | 65.5 | 233 | 67.3 |
Moretto et al, 2008 28 | NCT00381342 | D + E | 24 | 155 | 65.2 | 77 | 33.1 |
Gill et al, 2010 29 | NCT00516074 | Met and/or TZD | 12 | 28 | 5.8 | 26 | 5.7 |
Heine et al, 2005 22 | NCT00082381 | Met + SFU | 26 | 282 | 122.5 | 267 | 124.6 |
Nauck et al, 2007 23 | NCT00082407 | Met + SFU | 52 | 253 | 220.1 | 248 | 228.6 |
Davis et al, 2007 25 | NCT00099333 | SFU or Meg and/or Met | 16 | 33 | 7.7 | 16 | 5.2 |
Barnett et al, 2007 21 | NCT00099619 | Met or SFU | 16‡ | 136 | 37.3 | 127 | 38.9 |
Totals | Â | -- | -- | 2,316 | 1,071.6 | 1,629 | 779.9 |